Literature DB >> 19088278

Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis.

Keith N Leppard1, Edward Emmott, Marc S Cortese, Tina Rich.   

Abstract

Human adenovirus type 5 infection causes the disruption of structures in the cell nucleus termed promyelocytic leukaemia (PML) protein nuclear domains or ND10, which contain the PML protein as a critical component. This disruption is achieved through the action of the viral E4 Orf3 protein, which forms track-like nuclear structures that associate with the PML protein. This association is mediated by a direct interaction of Orf3 with a specific PML isoform, PMLII. We show here that the Orf3 interaction properties of PMLII are conferred by a 40 aa residue segment of the unique C-terminal domain of the protein. This segment was sufficient to confer interaction on a heterologous protein. The analysis was informed by prior application of a bioinformatic tool for the prediction of potential protein interaction sites within unstructured protein sequences (predictors of naturally disordered region analysis; PONDR). This tool predicted three potential molecular recognition elements (MoRE) within the C-terminal domain of PMLII, one of which was found to form the core of the Orf3 interaction site, thus demonstrating the utility of this approach. The sequence of the mapped Orf3-binding site on PML protein was found to be relatively poorly conserved across other species; however, the overall organization of MoREs within unstructured sequence was retained, suggesting the potential for conservation of functional interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19088278     DOI: 10.1099/vir.0.005512-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Adenovirus E4-ORF3-dependent relocalization of TIF1α and TIF1γ relies on access to the Coiled-Coil motif.

Authors:  Elizabeth I Vink; Mark A Yondola; Kai Wu; Patrick Hearing
Journal:  Virology       Date:  2011-11-27       Impact factor: 3.616

2.  Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.

Authors:  Yunyun Geng; Shamci Monajembashi; Anwen Shao; Di Cui; Weiyong He; Zhongzhou Chen; Peter Hemmerich; Jun Tang
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

3.  Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.

Authors:  Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

4.  The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription.

Authors:  Julia Berscheminski; Peter Groitl; Thomas Dobner; Peter Wimmer; Sabrina Schreiner
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

5.  Sp100 isoform-specific regulation of human adenovirus 5 gene expression.

Authors:  Julia Berscheminski; Peter Wimmer; Juliane Brun; Wing Hang Ip; Peter Groitl; Tim Horlacher; Ellis Jaffray; Ron T Hay; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

6.  PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.

Authors:  Delphine Cuchet; Amanda Sykes; Armel Nicolas; Anne Orr; Jill Murray; Hüseyin Sirma; Joerg Heeren; Alexander Bartelt; Roger D Everett
Journal:  J Cell Sci       Date:  2010-12-20       Impact factor: 5.285

Review 7.  Adenoviral strategies to overcome innate cellular responses to infection.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  FEBS Lett       Date:  2019-11-26       Impact factor: 4.124

8.  Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein.

Authors:  Asne Jul-Larsen; Amra Grudic; Rolf Bjerkvig; Stig O Bøe
Journal:  BMC Mol Biol       Date:  2010-11-21       Impact factor: 2.946

9.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

10.  Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication.

Authors:  Angela M Mitchell; Matthew L Hirsch; Chengwen Li; R Jude Samulski
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.